Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Unreliable detection of Mycobacterium xenopi by the nonradiometric Bactec MGIT 960 culture system.

Piersimoni C, Nista D, Bornigia S, Gherardi G.

J Clin Microbiol. 2009 Mar;47(3):804-6. doi: 10.1128/JCM.01444-08. Epub 2009 Jan 14.

2.

Impact of a chemistry-based DNA extraction method on performance of a commercial amplification assay for detection of Mycobacterium tuberculosis complex.

Piersimoni C, Gherardi G, Nista D, Bornigia S.

J Clin Microbiol. 2009 Jan;47(1):282-3. doi: 10.1128/JCM.00703-08. Epub 2008 Nov 19. No abstract available.

3.

Validation of the agar proportion and 2 liquid systems for testing the susceptibility of Mycobacterium tuberculosis to moxifloxacin.

Piersimoni C, Lacchini C, Penati V, Iona E, Fattorini L, Nista D, Zallocco D, Gesu GP, Codecasa L.

Diagn Microbiol Infect Dis. 2007 Mar;57(3):283-7.

PMID:
17338942
4.

Clinical suspicion as a primary guidance to use commercial amplification tests for rapid diagnosis of pulmonary tuberculosis.

Piersimoni C, Nista D, Zallocco D, Galassi M, Cimarelli ME, Tubaldi A.

Diagn Microbiol Infect Dis. 2005 Nov;53(3):195-200. Epub 2005 Oct 24.

PMID:
16249062
5.

Mycobacterium triplex pulmonary disease in immunocompetent host.

Piersimoni C, Zitti P, Mazzarelli G, Mariottini A, Nista D, Zallocco D.

Emerg Infect Dis. 2004 Oct;10(10):1859-62. Review.

6.

Mycobacterium lentiflavum as an emerging causative agent of cervical lymphadenitis.

Piersimoni C, Goteri G, Nista D, Mariottini A, Mazzarelli G, Bornigia S.

J Clin Microbiol. 2004 Aug;42(8):3894-7.

7.

Mycobacterium celatum pulmonary infection in the immunocompetent: case report and review.

Piersimoni C, Zitti PG, Nista D, Bornigia S.

Emerg Infect Dis. 2003 Mar;9(3):399-402. Review.

8.

Performance assessment of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex from respiratory and extrapulmonary specimens.

Piersimoni C, Scarparo C, Piccoli P, Rigon A, Ruggiero G, Nista D, Bornigia S.

J Clin Microbiol. 2002 Nov;40(11):4138-42.

9.

Direct identification of mycobacteria from MB/BacT alert 3D bottles: comparative evaluation of two commercial probe assays.

Scarparo C, Piccoli P, Rigon A, Ruggiero G, Nista D, Piersimoni C.

J Clin Microbiol. 2001 Sep;39(9):3222-7.

10.

Performance assessment of new multiplex probe assay for identification of mycobacteria.

Tortoli E, Nanetti A, Piersimoni C, Cichero P, Farina C, Mucignat G, Scarparo C, Bartolini L, Valentini R, Nista D, Gesu G, Tosi CP, Crovatto M, Brusarosco G.

J Clin Microbiol. 2001 Mar;39(3):1079-84.

11.

Comparison of MB/Bact alert 3D system with radiometric BACTEC system and Löwenstein-Jensen medium for recovery and identification of mycobacteria from clinical specimens: a multicenter study.

Piersimoni C, Scarparo C, Callegaro A, Tosi CP, Nista D, Bornigia S, Scagnelli M, Rigon A, Ruggiero G, Goglio A.

J Clin Microbiol. 2001 Feb;39(2):651-7.

12.

Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study.

Tortoli E, Cichero P, Piersimoni C, Simonetti MT, Gesu G, Nista D.

J Clin Microbiol. 1999 Nov;37(11):3578-82.

13.

Multicenter evaluation of the MB-Redox medium compared with radiometric BACTEC system, mycobacteria growth indicator tube (MGIT), and Löwenstein-Jensen medium for detection and recovery of acid-fast bacilli.

Piersimoni C, Scarparo C, Cichero P, De Pezzo M, Covelli I, Gesu G, Nista D, Scagnelli M, Mandler F.

Diagn Microbiol Infect Dis. 1999 Aug;34(4):293-9.

PMID:
10459480
16.

Isolation of Mycobacterium celatum from patients infected with human immunodeficiency virus.

Piersimoni C, Tortoli E, de Lalla F, Nista D, Donato D, Bornigia S, De Sio G.

Clin Infect Dis. 1997 Feb;24(2):144-7.

PMID:
9114138
17.

Comparative evaluation of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex in respiratory specimens.

Piersimoni C, Callegaro A, Nista D, Bornigia S, De Conti F, Santini G, De Sio G.

J Clin Microbiol. 1997 Jan;35(1):193-6.

18.

In vitro anti-Mycobacterium avium activity of N-(2-hydroxyethyl)-1,2-benzisothiazol-3(2H)-one and -thione carbamic esters.

Pagani G, Borgna P, Piersimoni C, Nista D, Terreni M, Pregnolato M.

Arch Pharm (Weinheim). 1996 Aug-Sep;329(8-9):421-5.

PMID:
8915105

Supplemental Content

Support Center